Clinical Trials Browser

Phase 2 × Multiple Myeloma × durvalumab × Clear all

NCT02807454 2023-02-21

FUSIONMM-003

Phase 2 Terminated

37 enrolled 21 charts

Multiple Myeloma, Recurrence

NCT03000452 2018-10-16

FUSION-MM-005

Phase 2 Completed

18 enrolled 16 charts

Multiple Myeloma, Recurrence